Keyword results: N50 website

PREMIUM CONTENT

OptiBiotix Health and SkinBioTherapeutics – further progress & triggers for dramatic 2022 re-rate

OptiBiotix Health (OPTI) was one of our tips of the year, with we anticipating financial progress as its deals for its compounds expand and further deals kick-in. It has now announced that a further human volunteer study on its cholesterol-reducing probiotic LPLDL - on a different population group of hypercholesterolemic adults – has shown “at six weeks, when volunteers taking placebo were compared to those taking LPLDL, there were statistically significant changes to clinically important cardiovascular risk”, including “34.2% reduction in total cholesterol (p=0.001)”.

Subscribe to ShareProphets to access Premium Content
BPM
BPM
PREMIUM CONTENT

B.P. Marsh & Partners – another deal, again suggesting value

Following recently a shareholding transaction in an investee company further suggesting value, B.P. Marsh & Partners (BPM) has now announced another deal suggesting the same.

Subscribe to ShareProphets to access Premium Content
THG
THG
PREMIUM CONTENT

The Hut Group (THG plc) – not an invitation to short but an obligation to

Shares in The Hut Group, THG plc (THG), listed at 500p in September 2020, then zoomed to 800p but now trade below 200p. Even so this business is still valued by the market at £2.2 billion.

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

In this market the cash-strapped who signal a placing are still a short

This is a market where being short can be exceedingly painful. As Gabriel Grego found out the other day, even what appear to be slam dunk frauds can roof it. This is what happens at the fag end of a bull market. But in the UK, I sense that there is now real ennui among investors, both institutional and the spivs at the bucket shops, when it comes to placings.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix Health – further partner agreements positives...

OptiBiotix Health (OPTI) has followed a sales agreement with Apollo Hospitals Enterprises for its GoFigure weight management product range in India with an agreement for GoFigure and SlimBiome Medical in Saudi Arabia (KSA). Is this further encouraging progress or just more flannel?

Subscribe to ShareProphets to access Premium Content
EZJ
EZJ
PREMIUM CONTENT

easyJet – a Recovery Buy?

An already widespread virus mutating to what is being seen clinically as “extremely mild cases”. Not bad news then… except in Airstrip One – and a resultant very negative stock market reaction. However government response madness is gradually being revealed and travel and leisure should resultantly gradually recover, though some share prices here remain depressed. Opportunity?…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

DS Smith – positive interims and outlook confidence, Buy

Packaging company DS Smith (SMDS) has announced results for its half-year ended 31st October 2021 and that it has “confidence to deliver a significant improvement in profitability during the second half of this year” following an increased pre-tax profit to £175 million in the first half.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Essentra – strategy and CFO update, formally adds to corporate excitement potential

Previously writing on Essentra (ESNT) we noted ‘Q3 update, adds corporate excitement potential’ with the company “reviewing the full range of strategic options for the Filters business” with it aiming to become a pure play Components business over time, targeting strategic focus and an acceleration of organic and inorganic growth. Now a further “Strategic Update” and a “Directorate Change”.

Subscribe to ShareProphets to access Premium Content
US-Flag-Blonde
PREMIUM CONTENT

Has the time for sanity in the US markets arrived?

Although the S&P 500 index is still around all time highs, there have been some savage declines of late in certain names and 275 stocks are lower now than they were six months ago. This suggests to me that the health of the US markets is much more fragile and precarious than the level of the three main indices implies.

Subscribe to ShareProphets to access Premium Content
VP
VP
PREMIUM CONTENT

Vp – interims, “strong and continuing recovery”. Buy

Equipment rental company Vp plc (VP.) has announced results for its half-year ended 30th September 2021 emphasising “a strong and continuing recovery in all of our businesses”. This sounds encouraging.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Another great chance to 'kick a man when he is down' – Tern

Evil Knievil: “the best time to kick a man is when he is down.” The great bear raider is correct, especially in these crazy times when so many frauds or near bankrupts seem able to defy gravity as the believers still belief and continue to BOTFD, so providing share price support. But in some cases even the believers are starting to smell the coffee.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

SkinBioTherapeutics – full-year results, still a “transformational” progress Buy?

SkinBioTherapeutics (SBTX) has announced results for its year ended 30th June 2021 emphasising “transformational” progress. So what is this?

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Macfarlane – trading ahead of expectations, Buy

Packaging group Macfarlane (MACF) has published a trading update including news that it “now expects the group will exceed its previous expectations for the full year”. Sounds good!

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix Health – launch of sports nutrition products to add £1m a year to sales, Buy

OptiBiotix Health (OPTI) has announced the launch of a new sports nutrition product range, LeanBiome, with a supply & licensing agreement with “a leading global player in beauty & nutrition”. What of a current share price response up to 42.5p?

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

The Botswana bounce and the cash strapped – a short list for shorting

I write after a day in which shares rallied sharply after Friday’s big sell-off. That shakedown was on fears that the Botswana covid variant or rather the extreme over-reaction to it given the level of hospitalizations and deaths it has caused (0 & 0) could see corporate earnings hammered. I noted on Friday that the sell off was driven by a false fear. Surely even the lunatics in charge of the asylum we call Britain will soon have to accept that the Omicron (an anagram of moronic) variant is no great threat and thus the new lockdown measures will have to be reversed and thus the impact on PLC earnings will be trivial. One would hope so. That growing realisation that our leaders have blundered is what, one suspects, drove the rally.

Subscribe to ShareProphets to access Premium Content

Atalaya Mining – Q3 “another strong quarter”, but what of a now more than 400p share price?

Atalaya Mining (ATYM) states it is pleased to announce its quarterly and nine-month results for the period ended 30th September 2021, with it emphasising “another strong quarter… robust operational performance, combined with strong copper prices, has seen our EBITDA for the first nine months of 2021 more than triple from the amount generated during the same period of 2020”. So what of a now more than 400p share price?

IMB
IMB
PREMIUM CONTENT

Imperial Brands – full-year results emphasise operational improvements, Buy

Imperial Brands (IMB) has announced results for its year ended 30th September 2021, emphasising “operational improvements supporting growth in net revenue, profit and free cash flow”.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

SkinBioTherapeutics – OptiBiotix’s share sale, who does it think it’s kidding?

Having been falling from early this month, shares in SkinBioTherapeutics (SBTX) are currently further lower after it announced “OptiBiotix Health Plc has placed 3,636,363 ordinary shares in SkinBioTherapeutics with new and existing institutional investors at a price of 55 pence per share”. With SkinBioTherapeutics CEO Stuart Ashman though arguing “the company is going from strength to strength” and “it is important to attract new investors who are keen to come on board to support us in the next stage of the company’s development, as a commercial entity”, why the further share price fall?

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Chill Brands – the best time to kick a man is when he is down

‘The best time to kick a man is when he is down’ is a quote from my friend the bear raider Simon Cawkwell, aka Evil Knievil. It is not a reference to individuals who have fallen on bad times for Cawkwell is, sometimes, not that uncharitable, but to shares in companies hitting new lows.

Subscribe to ShareProphets to access Premium Content
BP
BP

BP – Q3 results, positive cash generation and shareholder returns

BP (BP.) has announced third quarter of the year results, emphasising it is delivering significant cash to strengthen finances, growing distributions to shareholders and investing in strategic transformation.

Essentra – Q3 update, adds corporate excitement potential

Recommended at a 282.5p offer price in August, shares in Essentra (ESNT) are currently up to 289p on the back of a Strategic Update and Q3 2021 Trading”-titled announcement. Good news.

DS Smith – ‘more than offsetting input cost increases’, Buy

Packaging company DS Smith (SMDS) has announced for its half-year it is more than offsetting significant input cost increases, helped by continuing strong structural drivers of growth.

CSH
CSH
PREMIUM CONTENT

When a regulator works with a short seller you know the target is in trouble

Since, a few weeks ago, Matt Earl launched his first bear dossier on Civitas Social Housing (CSH) its shares have fallen by 25% to 91p. The company did issue a response to the first dossier published by the bear raider known as “the Dark Destroyer”.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

AltynGold – Q3 update, shares up but looks more to come

Gold miner in Kazakhstan AltynGold (ALTN) has made an update on the third quarter of the year, with the shares up as it noted that despite lower gold prices “strong production dynamics” still meant revenue was marginally up.

Subscribe to ShareProphets to access Premium Content

Atalaya Mining – Q3 performance sees increased production guidance, share price upside to come

Atalaya Mining (ATYM) has published a third quarter update including that it is now increasing its production guidance for the year. This sounds like good news.

PREMIUM CONTENT

Where is the promised quarterly sales update? – Chill Brands is a most compelling short

You can get borrow and you should. There is a collapsing long position on margin but the real reason to go aggressively short of Chill Brands (CHLL) is the deafening sound of silence. Let me explain.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Headlam – Chief Executive “stepped down”. Bad news or time for a change?

Floorcoverings distributor Headlam (HEAD) has announced that Steve Wilson has “stepped down” as Chief Executive and from the company having “been instrumental in the company’s success throughout his 30 years with Headlam, the last five years as Chief Executive”. Bad news or time for a change?

Subscribe to ShareProphets to access Premium Content
IMB
IMB
PREMIUM CONTENT

Imperial Brands – full-year trading statement, Income Buy

Imperial Brands (IMB) is “pleased to report the business continues to perform well… on track to deliver our full-year results in line with expectations”. That suggests upside potential from a below 1500p share price.

Subscribe to ShareProphets to access Premium Content
JSE
JSE

Jadestone Energy – new well onstream further boosts shares, more to come

Following half-year results from Jadestone Energy (JSE) recently, we noted the financial improvement despite challenges and that with the growth potential suggested the 77p share price too harsh an appraisal. There is now a Montara H6 well successfully brought onstream”-titled announcement and the shares are further higher.

JSE
JSE

Jadestone Energy – interims, production and cash flow growth to come

Jadestone Energy (JSE) has announced its results for the first half of 2021, reaffirming full-year production guidance of 11,500-13,500 barrels of oil equivalent per day and anticipating 20,000 boe/d towards the end of the year. We are well up on this 69p offer price share tip but where do we go from here?

BPM
BPM
PREMIUM CONTENT

B.P. Marsh & Partners – half-year trading update, reasons for confidence

Early stage financial services businesses investment company B.P. Marsh & Partners (BPM) has made a trading update for its half-year ended 31st July 2021, including that its “portfolio has performed well during the period, and we expect this to continue through the group’s current financial year”.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

AltynGold – interims, results of capex “look promising”...

Gold miner in Kazakhstan, AltynGold (ALTN) has announced its results for the first half of 2021 and that the results of its capital expenditure “look promising”.

Subscribe to ShareProphets to access Premium Content
ARB
ARB
PREMIUM CONTENT

Times when it is best to retire to the pavilion

I have been a critic of Argo Blockchain (ARB) for an awfully long time. It is run by sharp promoters and backed by some nasty spivs. And it seems to me that it has failed woefully to address the issues flagged up a few weeks ago in the recent Boatman bear dossier HERE.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

SkinBioTherapeutics – ‘Business Update’, high margin profit potential moving materially closer

SkinBioTherapeutics (SBTX) has delivered a “Business Update” including that the commercial launch of AxisBiotix-Ps is on track for Q4 and has further encouraging potential, that SkinBiotix manufacturing scale-up with Croda (CRDA) is progressing to schedule and 30th June year-end cash totalled £4.6 million. Sounds good.

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ
PREMIUM CONTENT

Anglo Asian Mining – Zafar maiden JORC Mineral Resource adds to potential

Anglo Asian Mining (AAZ) has announced a maiden JORC Mineral Resource for its Zafar polymetallic deposit in the Gedabek contract area, Azerbaijan, which it argues is “extremely encouraging and will help underpin the company’s future long-term production growth”.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix Health – extends Seed Health territories, strong buy

OptiBiotix Health (OPTI) has announced further growth with an agreement to extend the territories of its deal with Seed Health.

Subscribe to ShareProphets to access Premium Content
BP
BP

BP – Q2 results, creating value now and for the future?

BP (BP.) has announced second quarter of the year results emphasising “generating value for our shareholders today while we transition the company for the future”. Sounds good, but what’s the detail?

Headlam – as suspected, “materially ahead of current market expectations”

Early in July we noted shares in Europe’s leading floorcoverings distributor Headlam Group (HEAD) looked a recovery buy at a 495p offer price, considering there clear potential for outperformance of forecasts based on the trading momentum and the operational improvement programme being implemented. A “Pre-Close Trading Update” sees the shares currently at 528p. Is there still further upside?

PREMIUM CONTENT

OptiBiotix Health – shares up on ‘trading and commercial update’, much further to go

OptiBiotix Health (OPTI) has made a “Trading and commercial update” including that sales are ahead of its expectations for the first six months of the year and that it “believes it is in a strong position to meet or exceed its full year sales forecast”. The shares have currently responded up to 49.5p but there looks much further to go.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Impellam – half-year results, recovery but more to come?

International staffing group Impellam (IPEL) has announced results for the first half of the year and that it is seeing “increasing positivity in our customer demands for our managed service and talent solutions across our markets”. This sounds encouraging.

Subscribe to ShareProphets to access Premium Content
GSK
GSK
PREMIUM CONTENT

GlaxoSmithKline – second quarter results, still a recovery buy

GlaxoSmithKline (GSK) has announced second quarter of the year results, including stating “strong commercial execution” and “we are likely to deliver full-year Adjusted EPS towards the better end of our guidance range”. So where now for the shares?, with they currently having responded back up to 1400p.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

DS Smith – disposal agreement further aligns it with FMCG and e-commerce customers

DS Smith (SMDS“is pleased to announce the proposed sale of its De Hoop paper mill in the Netherlands to De Jong Packaging for a cash consideration of €50 million (c. £43 million)”. Good news from this leading provider of sustainable paper-based packaging?

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Thoughts on Tern – Part 2

Bulls and bears in tech investment company Tern plc (TERN) can at least agree on one thing: the key to the investment case is its holding in Device Authority Ltd (DA Ltd), a provider of security solutions for IOT products. Tern holds 56.8% of DA Ltd’s equity and has to date lent it £3.1 million in convertible loan stock. The stake is carried at £12.8 million on the balance sheet (valuing the whole company at £22.5 million), representing 58% of the value of the portfolio. It is DA Ltd’s perceived potential that has seen Tern’s shares trade at multiples of its book value and been the hook upon which it has hung the majority of its 16 placings to date.

Subscribe to ShareProphets to access Premium Content
MRW
MRW

Wm Morrison – Apollo Global Management update, take profits?

We previously updated on Wm Morrison Supermarkets (MRW) including noting Apollo Global Management stating that “it is, on behalf of certain investment funds managed by it, in the preliminary stages of evaluating a possible offer for Morrisons” meant that we could still see further upside potential with a competitive bid situation developing. There has now been a further announcement from Apollo.

PREMIUM CONTENT

Headlam Group – a recovery buy?

A trading update earlier this month from Headlam Group (HEAD) included “total revenue for the year-to-date is now in-line with the 2019 comparator, having been slightly below for the four months to 30 April 2021” and “the company’s Operational Improvement Programme delivering revenue growth opportunities and cost improvements”. This combination suggests there is further recovery value in the shares.

Subscribe to ShareProphets to access Premium Content
IQE
IQE
PREMIUM CONTENT

Trading a bad stock like IQE

There are two ways of viewing IQE plc (IQE). One, mine, is correct. The other, as pushed by the share promoters, the numerous corporate brokers and financiers who see its constant demands for fresh debt and equity as something of a gravy train, is not. Let’s start with those who are wrong.

Subscribe to ShareProphets to access Premium Content
GSK
GSK
PREMIUM CONTENT

GlaxoSmithKline – a Recovery Buy?

FTSE-100 pharma and healthcare company GlaxoSmithKline (GSK) is currently engaged in somewhat of a battle with well known activist investor Elliott Advisors. However, that is about the level of change as change is coming and Elliott is only involved as it “believes GSK has a substantial value creation opportunity – 45% upside in its share price – ahead of Consumer Health separation and greater beyond”. We concur that there is an attractive value creation opportunity here…

Subscribe to ShareProphets to access Premium Content

DS Smith – further recovery and structural growth potential following full-year results?...

At 425p, shares in fully fibre-based, innovative packaging for consumer goods company DS Smith (SMDS) are well up on our 321.8p offer price November recommendation but is there more to come, particularly following results for its year ended 30th April 2021 and “accelerated opportunities a post-Covid-19 world offers”?…

MRW
MRW
PREMIUM CONTENT

Wm Morrison – recommended offer, but is there still more to come?

Wm Morrison Supermarkets (MRW) is “pleased to announce” a recommended offer for the company from Fortress Investment Group at 252p per share plus a 2p per share dividend. That compares to a 181.75p offer price recommendation on this website just in January this year…but also a current 267.5p share price. Why the latter?…

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

Sell Tern, but Kier a buy...

Misguided excitement over the imminent IPO of investee company Wyld Networks has propelled the shares of Tern plc (TERN) to 27.5p, giving it a market value of £88 million and providing, in my opinion, a decent entry point for a short position.

Subscribe to ShareProphets to access Premium Content
EUA
EUA
PREMIUM CONTENT

Lucian Miers writes to Eurasia Mining

Lucian is short of Eurasia Mining (EUA) and for a host of reasons I think he is right to be short. One of those reasons is a mystery shareholder. Lucian has written to Eurasia’s boss Christian Schaffalitzky and his letter, still not having received a response after several days, follows:

Subscribe to ShareProphets to access Premium Content

J Sainsbury – recently risen fast for a FTSE ‘elephant’ and another dividend secured, so...

Recommending shares in J Sainsbury (SBRY) as an Income portfolio buy in November at a 199.7p offer price, we noted grocery and general merchandise sales had remained strong to date in its second half of the year and suggested a 260p+ share price achievable. Little more than 7 months later the shares are already nearly there.

BPM
BPM
PREMIUM CONTENT

B.P. Marsh & Partners – full-year results, recovery opportunities

Insurance businesses investor B.P. Marsh & Partners (BPM) has announced results for its year ended 31st January 2021, emphasising “total shareholder return of 10.1% for the year including the dividend paid in July… remain optimistic that we will be able to secure scalable and high growth investments, which will deliver substantial shareholder returns over time”. That sounds good to us.

Subscribe to ShareProphets to access Premium Content
EUA
EUA
PREMIUM CONTENT

Funny Money, odd placings, smells all wrong...

Lucian Miers wrote about one aspect of Eurasia Mining (EUA) that smells all wrong to him the other day. My friend and colleague is yet to get any satisfactory answers on that matter. But here is another oddity.

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ
PREMIUM CONTENT

Anglo Asian Mining – ‘pleasing’ 2020 results, Buy

Miner in Azerbaijan Anglo Asian Mining (AAZ“is pleased to announce its final audited results for the year ended 31 December 2020” and emphasises “exciting development opportunities”. Though don’t they all say that?

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Atalaya Mining – Q1 results, strong financial delivery

Atalaya Mining (ATYM) has announced what it describes as “strong financial results achieved in Q1 and look forward to the rest of the year, with confidence”. How strong?

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

AltynGold – “pleased to announce” Q1 update, we can understand why: BUY

Kazakhstan gold miner AltynGold (ALTN“is pleased to announce its 1Q21 production results and financial update”, and the shares have currently responded approaching 10% higher to 172.5p. So what’s the news?

Subscribe to ShareProphets to access Premium Content
SLP
SLP
PREMIUM CONTENT

Buy Sylvania Platinum

On banking near 300% gains on Jubilee Metals (JLP) earlier this year, we noted still significant positives but management actions which were not comfortably supportable. On fundamentals, at 20p, Jubilee still looks to have 10% upside, or arguably more, which is why Tom Winnifrith & Steve Moore remain shareholders but we cannot, in good conscience, tip shares in a company where there are such clear corporate governance issues. So, on that basis, the following looks a good replacement for it .

Subscribe to ShareProphets to access Premium Content
VRS
VRS
PREMIUM CONTENT

A golden rule about companies that threaten legal action

Of course, there are some instances when it is appropriate to take legal action against some critic. If, for instance, the attacks are against wives and children, there is a threat of actual body harm or the allegations are just so outrageous (paedophilia for example) then a company might justifiably take action. But simply to bring in lawyers, who are always expensive, to try to silence someone who criticises a company’s business model, or its valuation, is a monumental red flag.

Subscribe to ShareProphets to access Premium Content
JSE
JSE
PREMIUM CONTENT

Jadestone Energy – “pleased to announce” Malaysia acquisition. We can understand why

Jadestone Energy (JSE) is pleased to announce an agreement to acquire an interest in Peninsular Malaysia – and we can understand why.

Subscribe to ShareProphets to access Premium Content

J Sainsbury – full-year results show there is still income value

J Sainsbury (SBRY) has announced results for its year ended 6th March 2021 and that it has “carried good underlying trading momentum into the new financial year and started the year strongly”.

ZOE
ZOE
PREMIUM CONTENT

Leverage can hurt bulls as well as bears – watch Zoetic collapsing

Given that it has lied on an industrial scale to investors, regulators and consumers and managed first half sales of just £54,000, I think it will not surprise anyone terribly that I view the fair value of shares in Zoetic International (ZOE) as 0p. But I published all the evidence of the malfeasance and parlous financials and the shares still headed to well over 100p valuing this company at more than £200 million. That was two months ago. Now they are 57p to sell and falling fast. If you can short you should do so as this should be a penny stock really very soon.

Subscribe to ShareProphets to access Premium Content

Ferrexpo – Q1 production report, there remains upside potential from this cracking share tip

Iron ore pellet producer in Ukraine, Ferrexpo (FXPO) has announced a first quarter 2021 production report which includes it noting some ongoing pelletiser upgrade work impact though also that there has been some additional production, in terms of high-grade concentrate…

BP
BP
PREMIUM CONTENT

BP – trading and net debt position ahead of expectations, Income Buy

An “update on progress towards net debt target”-titled announcement from BP (BP.), which includes a claim of “earlier than anticipated delivery of disposal proceeds combined with very strong business performance during the first quarter”. This sounds good…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

SkinBioTherapeutics – new research programme - we are already 250% up but far more to come

Noting that “there is now an extensive growing body of research demonstrating direct links between the microbiome and the immune system, and consequently skin health”, SkinBioTherapeutics (SBTX) has announced initiation of a research programme with the University of Manchester.

Subscribe to ShareProphets to access Premium Content
CEY
CEY
PREMIUM CONTENT

Centamin – remains a recovery buy

Gold miner in Egypt Centamin (CEY) announced results for the 2020 calendar year emphasising “record revenue of US$829 million… generated significant free cash flow, of US$142 million, a 91% increase, making it possible to propose and pay dividends attributable to 2020 of US$104 million”  but also ‘impacted guidance’. A recovery buy?

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Ferrexpo – full-year results, still further upside to come on this cracking share tip?

Ferrexpo (FXPO) has announced results for the 2020 calendar year and that it expects to deliver a further increase in production this year. It is all looking good…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

AEX Gold – development plan and exploration progress, still a buy

Following recent Nalunaq project development delay disappointment, AEX Gold (AEXG) has noted progress in reviewing the development plan and of exploration work.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix Health – strong commercial progress & company chat: this will be inflexion year: buy

OptiBiotix Health (OPTI) has announced a “Commercial strategy update” which shows strong progress in its strategy to initially build sales and brand presence and then move up the value chain by selling more product than ingredients and commercialising further compounds. We’ve also had a catch up chat with CEO Steve O’Hara. This should be THE YEAR when profits come close to or exceed £1 million.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Biffa – a Recovery buy?...

Biffa plc (BIFF) describes itself as “the UK’s leading sustainable waste management business”. This FTSE 250 company has, like many, suffered from the lockdown restrictions but previously not as significantly as it feared and there looks further recovery and growth potential ahead not discounted in the share price…

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ
PREMIUM CONTENT

Anglo Asian Mining – provisional agreement terminates, but is this good news?

In July we noted on Anglo Asian Mining (AAZ) a provisional agreement for a “first enterprise outside of Azerbaijan”. Now it has announced those discussions have been terminated. Is a little changed share price response correct?

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

A Couple of Index Pairs for Turbulent Times

In these times of unprecedented uncertainty, it is not a great idea to make bold predictions about anything related to the markets and if ever there was a good time for sitting on the sidelines it is surely now. I will therefore make two not very bold and related predictions with which I feel comfortable…

Subscribe to ShareProphets to access Premium Content
PRE
PRE
PREMIUM CONTENT

Pensana – a buy again?...

Pensana (PRE) – now to be listed solely in London after giving notice to de-list in Australia - is progressing towards establishing the world’s first fully sustainable mine to magnet metal supply chain – materials for emerging industries including electric vehicles and wind turbines. The shares reached 120p early this year, since when the company has announced further progress towards its mine-to-magnet metal goal, but the shares are now lower…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

AEX Gold – sincere apologies for Nalunaq development disappointment, but average down

There is an “Update on Nalunaq Development” announcement from AEX Gold (AEXG) which we apologise for and about which CEO Eldur Olafsson was also very apologetic in a chat we’ve had. He damn well should be…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

AltynGold – “pleased to announce” Q4 production update and we can understand why, shares still cheap

Kazakhstan gold miner AltynGold (ALTN) is “pleased to announce” a fourth quarter 2020 production update – and the shares have currently responded a pleasing circa 30% higher. So what’s behind the re-rate?…

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ
PREMIUM CONTENT

Anglo Asian Mining – special dividend & “significant opportunities” - still more upside in the shares

Good News! There has been a ‘special dividend’ announcement from gold, copper and silver producer in Azerbaijan Anglo Asian Mining (AAZ), with it noting that it has delivered expected strong cash generation. So what’s the detail?…

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ
PREMIUM CONTENT

Anglo Asian Mining – potentially “great” restored contract areas potential...

Anglo Asian Mining (AAZ) has updated investors on the status of its three restored contract areas located in formerly occupied territories and Nagorno Karabakh following the Azerbaijan & Armenia ceasefire agreement…

Subscribe to ShareProphets to access Premium Content
JLP
JLP
PREMIUM CONTENT

Jubilee Metals – “Support from Blue Chip Institutional Investors” announcement takes the piss...

Support from Blue Chip Institutional Investors”-titled announcement from Jubilee Metals (JLP) is actually a disappointing lack of support from directors. This is with investment by the institutional investors ‘facilitated’ not only by a partial conversion of the convertible loan note held by ACAM LP, which facilitated the acquisition of the Sable Refinery in 2019, but also by director share sales…

Subscribe to ShareProphets to access Premium Content
MRW
MRW
PREMIUM CONTENT

Wm Morrison – an Income buy?...

We’ve produced an update on a positive trading statement from J Sainsbury (SBRY) but it is not the only one in its sector that, despite recent gains, looks to offer long-term income value…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

DS Smith – our quick gains added to on half-year results, still more to come?...

Recent recommendation packaging company DS Smith (SMDS) has announced results for its half-year ended 31st October 2020 and that there’s “growing momentum into H2”…

Subscribe to ShareProphets to access Premium Content

AltynGold – “pleased to announce” quarterly results, so why a further share price fall?...

AltynGold (ALTN) has updated on the third quarter of the year, stating that it is “pleased to announce” the results. So why has the share price response been a fall?…

JLP
JLP
PREMIUM CONTENT

Don’t go selling your Jubilee Metals now – although this has been a cracking share tip, price target almost doubled to 16p...

We tipped Jubilee Metals (JLP) at a 4.6p offer in July 2020. Ding Dong! As we approach Christmas the shares are circa 11p, making we loyal investors pretty happy. But do not even think of selling. Here’s why:

Subscribe to ShareProphets to access Premium Content
RMS
RMS
PREMIUM CONTENT

Remote Monitored Systems – sorry to Drone On...

Two weeks ago Remote Monitored Systems (RMS) shares traded at 2.65p giving the company a market cap of £40 million. I warned you then in this column and have since been double vindicated. The shares are 2.25p now but that is still far too high…

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

Premier Oil – now a post debt restructuring deal announcement sell

In my experience there are often opportunities to be had in shorting a company’s shares in the period after a debt restructuring deal has been announced as shareholders are generally slow to grasp the effect of the dilution on their interests…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

DS Smith – a Recovery buy...

An early this month “Pre-close statement” from DS Smith (SMDS) included “corrugated box volumes in and throughout Q2 have returned to growth… The step-change in use of e-commerce is clearly established across our territories with very high demand from customers for e-commerce packaging as we head into the festive season”. The shares responded higher… but the current share price compares to approaching 400p early this year and, with also a dividend expected for the company’s half-year which ended 31st October 2020, there looks further recovery value here…

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ
PREMIUM CONTENT

Anglo Asian Mining – updated guidance, outlook little diminished. Buy...

We’ve previously noted on Anglo Asian Mining (AAZ) some impact from the conflict between Azerbaijan and Armenia “due to the conscription of a number of engineering staff and some recently encountered temporary delays due to underground rock faulting”. Now “Updated Guidance for Turnover and Production”…

Subscribe to ShareProphets to access Premium Content
IMB
IMB
PREMIUM CONTENT

Imperial Brands – resilient full year results, Income buy...

Imperial Brands (IMB) has announced results for its year ended 30th September 2020 and that, despite showing resilience, “we expect to deliver a stronger financial performance in 2021”…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

J Sainsbury - an Income buy?

Recently-announced results from J Sainsbury (SBRY) included “sales (excluding VAT) down 1.1 per cent” and “loss before tax £(137) million”. The shares responded lower – but that after recently rising and they are now back on the rise again and we can see why…

Subscribe to ShareProphets to access Premium Content
JLP
JLP
PREMIUM CONTENT

Jubilee Metals – full-year results & record operational earnings...BUY

Metals processing group Jubilee Metals (JLP“is pleased to announce its audited results for the year ended 30 June 2020” and that “post the period under review… PGM and chrome operations delivered record quarterly operational earnings of £15.17 million”

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ

Anglo Asian Mining – updated mineral resources and ore reserves, still a risk/reward buy...

Anglo Asian Mining (AAZ) has announced updated mineral resources and ore reserves and that “our ongoing exploration programme targeting five new deposits is also expected to produce additional ore sources”

US-Flag-Blonde
PREMIUM CONTENT

Time to Buy BP on a Biden Win?

In a recent MoneyWeek article, entitled “Bargain Britain”, its writer Max King asserts:

Subscribe to ShareProphets to access Premium Content
BP
BP
PREMIUM CONTENT

BP – Q3 results, “Performance improving despite difficult environment”?...

BP (BP.) has announced its Q3 results emphasising “Performance improving despite difficult environment”…

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

Shorting even frauds is like pissing into the wind

It is not just in mining juniors where some valuations are bonkers or among those stocks that have jumped onto the Covid bandwagon, madness seems writ large across the market. But perhaps there is a madness in valuations which cannot be justified on fundamentals and that is that the market is telling you that are living through another asset bubble?…

Subscribe to ShareProphets to access Premium Content
CEY
CEY
PREMIUM CONTENT

Centamin – near-term production outlook disappointment, but the long-term promise remains...

Gold miner in Egypt Centamin (CEY) has updated emphasising “the third quarter marked another solid performance”, yet the shares have dropped back to 131.3p. The reason is a reduction in guidance for 2021 but the market has over-reacted…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

How should a cash-strapped enterprise spend its last pennies? ref. Verditek

What would you do if you were running a PLC with almost no cash and which was burning cash? It is a position I have been in and it is not a good place to be. You cut costs perhaps? Or you just do whatever is needed to raise fresh equity whatever the cost involved in doing that…

Subscribe to ShareProphets to access Premium Content
BPM
BPM
PREMIUM CONTENT

B.P. Marsh & Partners – interims, NAV growth & positive outlook...

B.P. Marsh & Partners (BPM) has announced half-year results emphasising that its “diversified investment portfolio has shown its resilience, delivering NAV growth despite the ongoing market uncertainty. The outlook is positive for the rest of the year”…

Subscribe to ShareProphets to access Premium Content
CEY
CEY
PREMIUM CONTENT

Centamin – a Gold buy...

We recommended shares in Centamin (CEY) amidst market panic in March and they rose faster than even we expected, seeing us take a more than 60%, little more than 1 month, profit. They went on to above 230p, but are currently 160p to buy following a “Sukari Operational Update”. We believe there to have been a big over-reaction to that update and so…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – Australia & New Zealand OptiBiome products launch, Asia to follow?...

OptiBiotix Health (OPTI“announces the launch of meal replacement shakes and bars containing OptiBiotix’s OptiBiome® proprietary weight management technology under the Optislim® brand with Woolworths, Chemist Warehouse and on OptiPharm Pty Ltd’s online store in Australia and New Zealand”…

Subscribe to ShareProphets to access Premium Content
VRS
VRS
PREMIUM CONTENT

Versarien & Innovate UK loan – a less feeble and more transparent response needed

Readers may recall reading the following paragraph from a letter of 27th July by junior minister Amanda Solloway to fellow MP Bim Afolami, seeking to justify the £5 million loan made by Innovate UK to Versarien (VRS):

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Supply@ME Capital and the mystery of Carrefour

There is a small amount of borrow available to allow you to short Standard Listed Supply@ME Capital (SYME) and after this week you should, if you can, grab it with the shares at 0.44p. The market cap is still well over £100 million and this is a zero in waiting…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – further expands SlimBiome Medical geographical reach, still a strong buy...

OptiBiotix (OPTI) has announced that it is “pleased to have signed an agreement with UITC to distribute our award-winning medical device in Singapore”…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Verditek – now at the slow death or quick death point...

I am told that you can get borrow in Verditek (VDTK) and that the stock is now shortable. For the avoidance of doubt I am not short, I never am since it would allow folks who own shares in frauds, engage in frauds or promote or enable them to accuse me as having a vested interest and thus compromise my status as an investigative journalist. But if you are into shorting here’s why this company is now at the slow death or quick death point…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – LPLDL & CholBiome distributor agreement, strong buy...

OptiBiotix Health (OPTI) is “pleased to announce… an exclusive distribution agreement with Ayalla Marketing for the distribution of its cholesterol reducing probiotic, LPLDL®, as an ingredient and as four finished products (CholBiome, CholBiomeX3, CholBiomeBP and CholBiomeVH) within the CholBiome® portfolio for Brazil”

Subscribe to ShareProphets to access Premium Content
JLP
JLP
PREMIUM CONTENT

Jubilee Metals – “Mining Licence Renewed and Board Appointment”, further positives...

Jubilee Metals (JLP“is pleased… the company has received notification from the Minister of Mines and Mineral Development in Zambia of the approval of the company’s application for the renewal of Small Scale Mining Licence 7081-HQ-SML in Kabwe… and… appointment of Nicholas (Nick) Taylor as non-executive director”…

Subscribe to ShareProphets to access Premium Content
BPM
BPM
PREMIUM CONTENT

B.P. Marsh & Partners – a “pleased to provide” trading update from the company...

B.P. Marsh & Partners (BPM“is pleased to provide the market with an update on trading for the six months ended 31 July 2020”, including of specific developments within its portfolio of financial services businesses investments…

Subscribe to ShareProphets to access Premium Content
WG
WG
PREMIUM CONTENT

Wood Group – a recovery buy?

Wood Group (WG.) announced half-year results including “operating profit of $65.6m (June 2019: $138.8m)…considers it prudent not to pay a 2020 interim dividend” but the shares look to be at a depressed valuation and the announcement also included “recent signs of stabilisation… expect good cash generation and a further reduction in net debt in the second half. Well placed for medium term growth as markets recover and the energy transition gathers pace”…

Subscribe to ShareProphets to access Premium Content
JLP
JLP
PREMIUM CONTENT

Jubilee Metals – ore supply and processing agreement continues expansion...

Jubilee Metals (JLP) has announced an ore supply and processing agreement which “not only significantly extends the life of the existing PGM resource but also offers the potential for Jubilee to significantly expand its Inyoni Operations”…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Directa Plus is insanely overvalued but does that mean its shares will fall?

An early morning tweet comes to me from an investor in Directa Plus (DCTA) suggesting that, although the share is speculative it is “under the radar screens of AIM tipsters” and insanely cheap. At 83p the Italian-run company is valued at £51 million so I suspect it has already received a good bit more than zero coverage.

Subscribe to ShareProphets to access Premium Content
BKY
BKY
PREMIUM CONTENT

Berkeley Energia – argues “a significant permitting milestone”...

Previously updating on Berkeley Energia (BKY) last month with the shares at 29p we noted there remain clear bureaucratic hurdles to overcome but at least progress was being made and economics in support of the project increasing given the current macro situation. Now “Urbanism Licence Granted for Retortillo”…

Subscribe to ShareProphets to access Premium Content
JLP
JLP
PREMIUM CONTENT

Jubilee Metals – further copper agreement expedites & expands potential in Zambia...

“Further Copper Tailings Resource Secured in Zambia” announcement from Jubilee Metals (JLP), with it emphasising this looking “to deliver copper units well in advance of Jubilee’s previously announced copper transaction in Zambia and is significant step towards achieving Jubilee’s stated goal of 25 000 tonnes per annum of copper production”…

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ
PREMIUM CONTENT

Anglo Asian Mining – exploration progress and to expedite in H2...

Returning after a previous profitable recommendation of shares in Anglo Asian Mining (AAZ), in July with the shares at 140p we noted current mines potential but also a geological exploration programme continuing with success. Now an “H1 2020 Geological Exploration Activities” update…

Subscribe to ShareProphets to access Premium Content
BP
BP
PREMIUM CONTENT

BP – results and dividend cut… we’re not surprised the shares rise…

BP (BP.) has announced second quarter and half-year results including “underlying replacement cost loss for the quarter was $6.7 billion, compared with a profit of $2.8 billion for the same period a year earlier… A dividend of 5.25 cents per share was announced for the quarter, compared to 10.5 cents per share for the previous quarter” ($2.1 billion)… and the shares have responded higher to nearer 300p…

Subscribe to ShareProphets to access Premium Content
JLP
JLP
PREMIUM CONTENT

Jubilee Metals – a buy?...

Jubilee Metals (JLP), an AIM and Altx traded metals processing company, has recently followed a “pleased to announce” six month operations update with a compelling presentation at MineProphets and at a current 4.6p offer price…

Subscribe to ShareProphets to access Premium Content
TRN
TRN
PREMIUM CONTENT

Surely the boat has sailed for Trainline plc?

I am not a great train traveller so cannot boast vast first hand experience of using the online booking service Trainline (TRN). However that does not stop me noting that at 415p the just under £2 billion market cap is quite utterly absurd…

Subscribe to ShareProphets to access Premium Content
BKY
BKY
PREMIUM CONTENT

Berkeley Energia – recommended extension of ‘Initial Authorisation’, further upside potential?...

Berkeley Energia (BKY“notes that the Board of the Nuclear Safety Council has issued a favourable report for the extension of the validity of the Initial Authorisation for the uranium concentrate plant as a radioactive facility at the Salamanca project following a board meeting held on the 22 July 2020”

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ
PREMIUM CONTENT

Anglo Asian Mining – provisional agreement for a “first enterprise outside of Azerbaijan”… Notwithstanding it, BUY

Anglo Asian Mining (AAZ) has announced a non-binding heads of terms agreement for its “first enterprise outside of Azerbaijan”...

Subscribe to ShareProphets to access Premium Content
AAZ
AAZ
PREMIUM CONTENT

Anglo Asian Mining – quarter and half-year update, remains a buy...

Q2 & H1 2020 Production and Operations Review” from Anglo Asian Mining (AAZ) including “on track to achieve forecast production for FY 2020 of 75,000 to 80,000 GEOs” (Gold Equivalent Ounces)...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – WellBiome distribution agreements, patience still required but still a strong buy...

OptiBiotix Health (OPTI) has recently been “pleased to announce the extension of terms for CTCThis agreement recognises CTC's success in building sales of SlimBiome® and extends terms to enhance further sales growth, supported by minimum sales targets. This is a first commercial step in bringing our new functional ingredient WellBiome® to global markets and building brand awareness” and pleased to announce… a second commercial step in bringing OptiBiotix's new functional ingredient WellBiome® to global markets and building brand awareness”...

Subscribe to ShareProphets to access Premium Content
BP
BP
PREMIUM CONTENT

BP – agreement to sell petrochemicals business, still a long-term income buy?

Shares in BP (BP.) closed the prior week heading down towards 300p but are currently back above 310p, particularly following an “agrees to sell petrochemicals business to INEOS” announcement...

Subscribe to ShareProphets to access Premium Content
R4E
R4E
PREMIUM CONTENT

Reach4Entertainment – 2019 results, “confidence in the group's ability to withstand the current situation”...BUY

Live performance and entertainment marketing group Reach4Entertainment (R4E) has announced results for the 2019 calendar year, including “confidence in the group's ability to withstand the current situation and… anticipates that when live venues finally reopen - at whatever capacity - the requirement to market shows should ensure that r4e quickly returns to previous levels of trading”...

Subscribe to ShareProphets to access Premium Content
HGM
HGM

Highland Gold Mining – “Update on COVID-19 Response”, continuing as planned...

Highland Gold Mining (HGM) has updated on its COVID-19 response, with its programme of measures enabling its mining, processing, sales, supply chain and capital construction projects to ‘continue as planned’...

Bear
PREMIUM CONTENT

Sandbagged by Hertz

It is self-evident that stop losses are important, particularly when it comes to short selling where potential losses are infinite but I have always set the limit high with obviously bust companies and been relatively relaxed when they have moved against me, as it is usually an opportunity to sell more...

Subscribe to ShareProphets to access Premium Content
BP
BP

BP – new CEO sounding loony… or being very clever?

“revises price assumptions; expects charges at 2Q” announcement from BP (BP.), including February-commenced CEO Bernard Looney stating “in February we set out to become a net zero company by 2050 or sooner… we have been reviewing our price assumptions over a longer horizon. That work has been informed by the COVID-19 pandemic, which increasingly looks as if it will have an enduring economic impact”. Loony or very clever?...

Bear
PREMIUM CONTENT

Two UK shares which cannot defy gravity forever...

We live in mad times. In the wider world I see that cartoon Police Dog Chase, from Paw Patrol, is about to go the way of Thomas Guy and Gladstone and become a non-person. On the stockmarket we see shares in companies that had said they are in a real mess, entering Chapter 11 in the USA, or talking to an administrator in the UK, roof it. This is all sheer madness and cannot last. I offer you two UK examples...

Subscribe to ShareProphets to access Premium Content
BPM
BPM
PREMIUM CONTENT

B.P. Marsh and Partners – full-year results, dividend & argues resilience...

B.P. Marsh & Partners (BPM) has announced results for it year ended 31st January 2020, including “we are pleased to be able to deliver a dividend at this time”, noting “at this juncture Covid-19 appears unlikely to negatively influence the portfolio as a whole in a material fashion”...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Altyn – updates on production & financing progress, up 60% in a month but still a buy?

Previously updating on Kazakhstan-focused gold company Altyn (ALTN) last month with the shares rising above 1p, we noted emphasises “significant production increase”, still a buy. Now from the company a Production and financing update – and the shares currently up to 1.60p on the back of it...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – clarifications and updates on more news from the company

More news from OptiBiotix Health (OPTI) and we’re also asked to clarify re. previous statements by the company...

Subscribe to ShareProphets to access Premium Content
VLE
VLE
PREMIUM CONTENT

Volvere – 2019 results… and 2020 opportunities…

Volvere (VLE), the growth and turnaround investment company, has announced results for the 2019 calendar year, that its trading, food manufacturing, businesses “are still achieving an encouraging level of output” and that it is “already seeing increased levels of distressed deal flow”...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – shares down on historic numbers but look at the trading trajectory now...

Currently compounds to tackle obesity, high cholesterol and diabetes developer, OptiBiotix Health (OPTI) has announced results for the 13 months to 31st December 2019 (having moved its year-end from November), emphasising it “has met a significant number of important objectives that continue to build value for shareholders”. The shares have currently responded a bit lower to 62p, but the numbers are historic and look at the trading trajectory now...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – builds on recently announced SlimBiome product launches, building compelling value…

Updating on OptiBiotix Health (OPTI) earlier this week we noted interest from larger partners and shorter partner discussions as sales are significantly developing. Now “a non-exclusive license agreement for its SlimBiome® trademark with Evolution_18 and related launch of fibre gummies containing OptiBiotix's SlimBiome® proprietary weight management technology”

Subscribe to ShareProphets to access Premium Content
IMB
IMB
PREMIUM CONTENT

Imperial Brands – cuts dividend… but as we expected and still an Income buy

We recommended shares in tobacco and ‘next generation’ products smoking company Imperial Brands (IMB) amidst the market instability in early April – noting trading performance resilience although we regarded a dividend cut as almost inevitable. The company has now announced results for its half-year ended 31st March 2020 – and there’s subsequently been a new addition to the shareholder list...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – sales trajectory sparks shares, but still an even stronger buy...

OptiBiotix Health (OPTI) has updated including noting first quarter of 2020 sales of £407,844 – and the shares have responded 11% higher to above 60p. Capitalising the company at around £53 million, why you may ask? Well, look at the company’s trajectory...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Altyn – emphasises “significant production increase”, still a buy

Kazakhstan-focused gold company Altyn (ALTN) has updated on Q1 production, emphasising “production up a significant 130% year-over-year” and also that there is presently “minimal” COVID 19 pandemic impact on the operations, with it “closely monitoring the situation while cooperating with relevant authorities”...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

The housing market is NOT reopening, 1 of two reasons to revisit Purplebricks...

Since warning you not to be short as the market almost bottomed it has been painful for those who ignored my advice. But I sense that a few opportunities may be opening up again. There is something Orwellian in the way that our Government makes statements about the Corona economic mess it has created with its non-sensical policies, the MSM parrots them and then as a nation we are expected, when not applauding the NHS or snitching on our neighbours for having two walks a day, to repeat and accept. And so we are told that the housing market is “opening up again.” And that swift action in getting housebuilders back to work & allowing estate agents to go to back to lying to buyers and sellers alike, will protect the nation’s favourite obsession, house prices...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – now Taiwan agreement adds to confidence...

OptiBiotix Health (OPTI) has announced it’s “pleased to have signed an agreement… to commercialise our award-winning weight management technology in Taiwan”

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – license agreement; potentially very exciting, Strong Buy...

OptiBiotix Health (OPTI) has announced “a non-exclusive license agreement for its SlimBiome® trademark with Smart For Life, Inc. and related launch of cookies containing OptiBiotix's SlimBiome® proprietary weight management technology in the USA and Canada”...

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

Sell sub prime auto loan shark Credit Acceptance Corporation

The tug of war going on in the markets now between reality and full on Modern Monetary Theory makes the stock market all but uninvestable until it is clear which side prevails. At the moment the latter seems to have the upper hand, but it is early days and I suspect that reality is not done yet. On the short side, many zombie companies which have been propped up since the GFC with artificially low interest rates are now sensing a new lease of life as they rush to the seemingly limitless Covid trough, as moral hazard abounds. There are always exceptions however...

Subscribe to ShareProphets to access Premium Content
HGM
HGM
PREMIUM CONTENT

Highland Gold Mining – shares bounce on quarterly operational update, looks more to come...

Shares in gold producer from Russia, Highland Gold Mining (HGM) are 5% higher at near 230p on the back of a quarterly operating update...

Subscribe to ShareProphets to access Premium Content
ROL
ROL

Rotala – trading statement, average-down buy?

Trading Statement from bus services provider Rotala (ROL) including that the directors believe that it “will be well placed to take advantage, when restrictions are lifted, of the increased opportunities in the bus market that were evident before the onset of the coronavirus epidemic”...

PREMIUM CONTENT

Hammerson a hero or a zero?

Covid-19 has changed the world. Well perhaps not the virus itself but the governmental response, which I continue to see as the biggest exercise in GroupThink madness the world has seen. But the change has come and a clear victim is Hammerson (HMSO), a heavily indebted owner of retail properties. Its last stated NAV was 601p, the shares trade at 84p. Either this is the cheapest stock going or something is so wrong that it could be horribly expensive...

Subscribe to ShareProphets to access Premium Content
AST
AST
PREMIUM CONTENT

More smoke and mirrors and plate-spinning from James Parsons..this time it is Ascent Resources

What are shares in Sound Energy (SOU) trading at today? 1p, 2p? I reckon this drowning in debt POS is worthless but only time will tell. It was not that long ago that shares in Sound traded at 90p. Not one institution bought as the stock headed to a £700 million market cap driven by obscene share ramping by the then CEO James Parsons, aided by some of the less scrupulous characters on the AIM scene...

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

Hoping the Corona legacy will bring some benefits (& a couple of bear tips)...

As I write the Dow is down 25% year-to-date and 28% from its all-time high struck seven weeks ago on Feb 12th. Amongst the maelstrom of opinion and statistics that surfaced in March, the fact is that none of us have a clue what the future holds – least of all the financial experts (Ray Dalio: “cash is trash”, Steve Mnuchin: “this is not a financial crisis but we need to print 3 trillion now”). It is encouraging that the new heroes are health workers and not hedge fund managers and clueless treasury officials. My view is that the falls do not remotely reflect the severity of the economic situation, but that is beside the point

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – new agreements suggest shares remain a strong buy...

OptiBiotix Health (OPTI) has followed an “Exclusive licence agreement for OptiBiome®” with a contract manufacturing agreement for SlimBiome® with Fipros A/S, emphasising “the agreement is key”

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

Two stocks which are clearly slam dunk zeros

Okay, I have been wrong with such calls before. Quindell (QPP) was a total and demonstrable fraud, running on fumes and so just had to be a zero... Then along came those Aussie poltroons from Slater & Gordon, who bought most of its worthless assets, so saving Quindell but train-wrecking their own company. It happens now and again that the corporate world throws up an even bigger fool than your average Bulletin Board Moron on the LSE Asylum. Moreover, these are “challenging” times...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – “Change of accounting year end”… but this one clearly sensible…

Change of accounting year end” announcement from OptiBiotix Health (OPTI). But isn’t that a move of fraudsters or incompetents? Not in this case…

Subscribe to ShareProphets to access Premium Content
GPM
GPM
PREMIUM CONTENT

Golden Prospect Precious Metals – a gold buy

Gold is still up from around $1,300 a year ago and current uncertainty and economic responses look to create a potential perfect storm for precious metals ahead. We believe this is a geared, but lower-risk way than most, to play it… The sell off of gold in the past week is a dash for cash to cover trading losses elsewhere. But that will not last and you MUST have gold exposure.

Subscribe to ShareProphets to access Premium Content
IND
IND

IndigoVision – recent tip gets recommended offer at a massive premium, now…

We recently recommended shares in IndigoVision (IND) at a 210p offer price and up to 225p, noting the company had been loss-making in recent years but a January trading update which offered encouragement having been followed by a full-year results announcement suggesting further potential. Now an announcement; Recommended cash acquisition of IndigoVision

PREMIUM CONTENT

Altyn – mining equipment purchases, gold production increasing…

Kazakhstan-focused gold company Altyn (ALTN) “is pleased to announce that significant progress has been achieved in the acquisition of mining equipment following the recent debt raising by the company”

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – modified and extended agreement RNS emphasises attractiveness & share price fall

I have communicated with Steve O Hara. The share price of Optibiotix (OPTI) is 34p and that is freaking some folks out. The share price does not reflect what is going on. I think a formal trading statement would be useful.

Subscribe to ShareProphets to access Premium Content
Tom
PREMIUM CONTENT

As an investor, doing nothing is generally under-rated (but sometimes the facts have changed)...

The oil price tanking - for reasons I explained at the weekend HERE - and shares tumbling across the board on concerns as to what damage the Coronavirus is doing, and will do, to the real economy and thus to corporate earnings. Generally, my view is that doing nothing as an investor is something that is greatly under-rated. It is perhaps better to wait until the smoke clears. Having said that, sometimes we need to accept that facts have changed and that does fundamentally alter an investment thesis...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Three stocks where a Coronavirus warning looks inevitable & not discounted

It may seem tasteless to consider such matters but the reality is that Covid 19 is spreading and whilst the numbers infected are still a drop in the ocean the fear is palpable and the effects on the real economy are already clear. The Fed may have slashed base rates by ½% earlier this week but, like the markets which promptly puked, I do not see this curing anything. Folks are not going to start spending again just because money is a bit cheaper, further cheap money will not solve a snagged up supply chain...

Subscribe to ShareProphets to access Premium Content
VLE
VLE
PREMIUM CONTENT

Volvere – an undeserved discount to last stated NAV, Buy!

September-announced half year results from self-styled “growth and turnaround investment company”, Volvere (VLE) included “net assets per share have reached a new record of £13.56 (30 June 2018: £6.75, 31 December 2018: £12.50)”. Despite this and clear further growth potential though, the shares are still available at a meaningful discount to that NAV and so…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix – developments to further support commercialisation

OptiBiotix Health (OPTI) has updated on a number of developments CEO Steve O'Hara emphasises “support the commercialisation of its ingredients and products”

Subscribe to ShareProphets to access Premium Content
FOX
FOX
PREMIUM CONTENT

Fox Marble – “Strategy Update” sees some more confidence return

Updating on Fox Marble (FOX) earlier this month, we noted we retain the patience for at least continuing to hold with the shares at 2.30p with the potential arbitration and it mitigating a forced quarry operations suspension with increased focus on the sales of processed material from the factory and “further contracts for third party processing are expected to be signed in the near future”. Further updates have now helped the shares to a current 2.90p…

Subscribe to ShareProphets to access Premium Content
BPM
BPM
PREMIUM CONTENT

B.P. Marsh and Partners – a buy

“The latest published Net Asset Value was £130m, or 360.9p per share, as at 31 July 2019, which represented a 3% increase, or a 4.3% increase including the dividend paid in July 2019, for the six months ended on that date. From its inception in 1990 until 31 July 2019 the group has maintained an average annual compound increase in NAV of 11.7%. The group is expected to report a positive performance for the financial year ended 31 January 2020.” What price for this track-record, current performance and ‘focussed on taking actions to reduce discount to net asset value’?... Presently, a 268p offer price and thus…

Subscribe to ShareProphets to access Premium Content
VLX
VLX
PREMIUM CONTENT

Volex – updates on manufacturing and China somewhat reassure, BUT…

Volex (VLX) has released a “Statement Regarding Current Situation in China” – it having four manufacturing plants in China…

Subscribe to ShareProphets to access Premium Content
ROL
ROL

Rotala – “in-line with market expectations” & outlook optimism…

Bus group Rotala (ROL) has updated including it “is pleased to announce that trading during FY 19 was in-line with market expectations”, that it “is well placed to capitalise on its enhanced position in a period when the bus industry continues to undergo considerable change” and that it “expects to maintain its progressive dividend policy”

Bear
PREMIUM CONTENT

Apple & Tesla: Are we getting close to the top?

Investors love to look for signs of markets tops, a difficult task, except in hindsight. A favourite of the GFC of 2008 was the infamous comment by Citigroup’s Chuck Prince in July 2007; “As long as the music is playing you have to get up and dance." Now we have another Prince, this time Bob, co CIO of Bridgewater, who proclaimed at Davos the other day that we have seen the end of the boom bust cycle (remember the great Gordon Brown saying much the same in 2007?)...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Solid State – we to now follow Chief Executive Gary Marsh?...

Solid State (SOLI) was a 500p offer price, October last year, share tip. It has since updated positively and, following a share price rise to well above 600p, there’s this month been director shareholding announcements…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

4 pieces of Optibiotix news but only 2 announced – I have never been so bullish

I am now a customer as well as a shareholder having ordered two boxes of Slimbiome to help me shift, ahem, a few pounds. I shall report back on my progress. But you want to gain pounds don’t you? Well at a 60p offer, the way to do that is to buy more Optibiotix (OPTI) shares. I have as I have never been more confident about the company and its prospects. Let me explain why with reference to the four bits of news out this week...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Optibiotix: I've bought more shares after badly written trading statement

If a trading statement needs explaining then it is badly written. Yet again Optibiotix (OPTI) stands accused of that. I really think the company should fire its PR PDQ. Frankly I could, and would, do a better job. As a result of a badly written release, folks are accusing boss Steve O’Hara of lying. He has not. Amid the confusion the shares have slipped to 50-52p. I have taken the chance to buy some more...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Shoe Zone – full-year results suggest still income and further recovery attractions: BUY

“The UK's largest value footwear retailer”, Shoe Zone (SHOE) has announced results for the 53-week period ended 5th October 2019 and that it “has made a solid start to the year and is trading in line with market expectations. The board is positive about the outlook for the year with the refreshed strategy well underway”

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix Health – first major retailer agreement (& look what’s set to follow…)

OptiBiotix Health (OPTI) has announced a first agreement with a major retailer for its SlimBiome® functional ingredient with a product range to be initially sold in the UK, Republic of Ireland, Netherlands, Belgium and Sweden by health food chain Holland & Barrett…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix Health – further medical device status & CE mark, further distribution agreements ahoy…

OptiBiotix Health (OPTI) is “very pleased to have been granted a medical device status and a CE mark for the second time over a 12-month period”...

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

Versarien, Bidstack & AFC Energy... short now or later?

All three are concept stocks and shares in all three will at some stage slide towards zero...

Subscribe to ShareProphets to access Premium Content
SXX
SXX
PREMIUM CONTENT

Time for General Inaction but still short Sirius Minerals

One of the most important disciplines in this game is knowing when to do nothing and until the UK election is out of the way I think it is wise to stay on the sidelines. My political predictive skills are far from perfect and while Johnson is fortunate to have Corbyn as an opponent and ought to gain an overall majority, which would almost certainly trigger a rally in sterling and the beaten up UK-based companies, I am happy to wait for the result before acting. The gulf between left and right both here and in the US is so huge that the idea that decent companies will prosper whatever the political outcome no longer holds good. As for the short side, as is usual at the tail end of a long bull market, the market is extremely tolerant of frauds and over-promotions which is extremely frustrating for bears...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix Health – further SkinBioTherapeutics shares sale reviewed

It has been announced OptiBiotix Health (OPTI) has sold 2.2 million further shares in 2017 spun-off onto AIM SkinBioTherapeutics (SBTX). This despite OptiBiotix’s results earlier this year including “SkinBiotherapeutics plc is making solid progress… As its partnership discussions turn into commercial agreements providing industry validation of its technology we anticipate SkinBiotherapeutics plc will grow in value, whereupon OptiBiotix shareholders will benefit from the appreciation of this asset”. So why the further sale?...

Subscribe to ShareProphets to access Premium Content
SXX
SXX
PREMIUM CONTENT

The best time to kick a man is when he’s down - ref. Sirius Minerals

Lucian Miers calls in from Cambodia where he is escaping the nonsense of the election campaign, to ask is Jo Swinson really as dim as she seems and is Mothercare (MTC) bust. I am afraid that I have no answer to either question...

Subscribe to ShareProphets to access Premium Content
BP
BP

BP – Q3 2019 results review

BP (BP.) has announced a third quarter underlying replacement cost profit of $2.3 billion, compared to $3.8 billion a year earlier, though also a maintained $0.1025 quarterly dividend per share and that it’s “making strong progress with our divestment plans and building exciting new opportunities in fast-growing downstream markets in Asia”

Crime-Scene
PREMIUM CONTENT

Tom Winnifrith asks: Is lying and fraud now acceptable on the London Market?

You will probably not have heard of BigDish plc (DISH) unless you have read my exposes HERE. It is a small and insignificant Standard Listed tech company. It is really only of interest because of the outrageous behaviour of its CEO.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Shoe Zone – full-year trading update. A recovery & income buy?

Previously commenting on Shoe Zone (SHOE) we noted it updating disappointingly but the Big Box and Digital growth elements of its strategy progressing, the latest balance sheet was still in decent shape and it not anticipating any change to dividend policy, with even just the ordinary dividend per share for last year totalled 11.5p – and thus to, at worst, hold. Now a “Full Year Trading Update” from this, the UK's largest value footwear retailer…

Subscribe to ShareProphets to access Premium Content
POG
POG
PREMIUM CONTENT

Petropavlovsk – Q3 operational update & ‘Positive’ outlook, still a buy?...

Petropavlovsk (POG) has updated on increased gold sales (to 126.4koz) and average realised gold price (to $1,388/oz) in the third quarter, with CEO Dr Pavel Maslovskiy emphasising “the smooth ramp-up has continued at the POX Hub where we have now successfully commenced treating third party concentrates during the quarter”

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Solid State – a buy for growth?

Company upon company is reporting they’re suffering amidst “heightened macroeconomic and political uncertainties of recent months” – or words to that effect. The quote there was from a trading update last month from Solid State plc (SOLI)… but the update also included that, notwithstanding… “trading in the first four months of the year has been very strong… is confident that profits for the year ending 31 March 2020 will be significantly ahead of expectations… consider there may be opportunities to generate further incremental sales later in the year”

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

OptiBiotix Health – validations look to significantly increase LPLDL potential, remains a strong buy

OptiBiotix Health (OPTI) has updated investors with news including “completing Pharmaceutical GMP process validation and receiving the GRAS notification letter from the US FDA is a significant achievement for ProBiotix and LPLDL®. Few marketed probiotics have achieved this level of proven safety and efficacy and it has triggered another milestone payment in the US Pharmaceutical agreement”

Subscribe to ShareProphets to access Premium Content

Altyn – pleasing Resources & Reserves upgrade, remains a gold recovery buy

Altyn (ALTN) “is pleased to announce the results of the latest Independent Competent Person’s Report for the Sekisovskoye Mine, which includes an important upgrade to its Mineral Resources and Ore Reserves estimates”

PREMIUM CONTENT

The Penny Finally Drops at PureCircle

Back in March, I suggested that PWC might like to brush up on the definition of a “Current Asset” with regard to the huge levels of inventory carried by PureCircle (PURE) relative to its annual sales...

Subscribe to ShareProphets to access Premium Content

Altyn – loan approval follows interims, Sekisovskoye production ramp up ahoy

“Funding update”, following half-year results from gold miner in Kazakhstan Altyn (ALTN)...

POG
POG

Petropavlovsk – interims & “now positioned to capitalise on higher gold prices and enhance cash generation”…

Petropavlovsk (POG) has announced results for the first half of 2019 including that it “remains on track to meet its full-year target of c.450koz - 500koz of gold sales (including the processing of 2018 Malomir stockpiles but excluding upside from third-party concentrate purchases)”, with also “the confidence to decrease total cash cost guidance for the full year to US$750 - US$850/oz”

VRS
VRS
PREMIUM CONTENT

Versarien – nearly time to deliver

Earlier this month Haydale Graphene (HAYD) released an announcement with the headline: Haydale Awarded Funding to Develop Airbus Approved Space Technology, in which a contract awarded by the European Space Agency was proudly proclaimed. The size of both the funding and the contract were not disclosed as is usually the case with these trifling disclosures and the Haydale share price (sub 2p) scarcely moved, leaving its market cap little changed at around £5 million. It struck me, however, that had Versarien (VRS) - market cap £167 million - made an identical RNS the market cap would probably have risen, at least temporarily, by several times that of Haydale’s total worth, such is the fervour that the company still inspires amongst its loyal retail following. But the point at which Versarien must start to deliver is approaching...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Ferrexpo – time for another go

Back in May I suggested buying shares in Ferrexpo (FXPO) at 207p on the basis that the sharp fall in the share price on the news of the resignation of the auditor was overdone and that a rally to 250p was likely. The good news for those that saw 250p as a target was that it was hit in short order, with the shares going on to 285p...

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Optibiotix – the interims do not impress but the shares really are a strong buy

Shares in Optibiotix (OPTI) have fallen by more than a quarter on the back on results for the six months to May 31 which are, let us not kid ourselves, really not very impressive indeed. The bears are cock-a-hoop but now talking errant nonsense. We bulls look a bit daft. As a shareholder I feel a bit sore but, having chatted to CEO Steve O’Hara at length, I retain a stance of strong buy. I see one director, Fred Narbel, has bought 17,000 shares at 50p and I expect more, larger scale, boardroom buying to follow. And this is why...

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

Another Crack at Wayfair

Early last December, I recommended selling online home furnishing retailer Wayfair (NYSE - W) at $105. Helped by that month’s broad market sell off it promptly fell to $80. However I managed to close the position for a small loss as it rampaged back through my sale price, hitting over $160 in February. My gripe with Wayfair was and still is that ever since its inception in 2002 it has been incapable of making money and the more it grows its revenues the bigger are its losses (Q2 YOY revenue up 41% to $2.3 billion, losses up 81% to $181 million)...

Subscribe to ShareProphets to access Premium Content
BUR
BUR
PREMIUM CONTENT

Lucian Miers' thoughts on the Burford fiasco

Last week’s saga of Burford Capital (BUR) illustrates well the febrile state of the markets right now and shows how easily ruffled both retail and institutional investors can be in the scandal-prone junior market...

Subscribe to ShareProphets to access Premium Content
VLX
VLX
PREMIUM CONTENT

Volex – trading & dividend ahead of expectations and further growth potential

Following a new revolving credit facility (up to $40 million “on significantly improved terms, which reflects the ongoing strength of our business”), there’s now AGM and acquisition announcements from recent share tip, Volex (VLX)…

Subscribe to ShareProphets to access Premium Content
BP
BP
PREMIUM CONTENT

BP – Q2 2019 results, an Income buy?

BP (BP.) has announced 2019 second quarter results, emphasising “continuing to deliver strong performance and strategic progress”

Subscribe to ShareProphets to access Premium Content
SNX
SNX
PREMIUM CONTENT

Synectics – results subdued again… but investment beginning to pay off?

Surveillance technology and networked security systems company Synectics (SNX) has announced results for its half-year ended 31st May 2019 and a contract win…

Subscribe to ShareProphets to access Premium Content
POG
POG
PREMIUM CONTENT

Petropavlovsk – “Heavy Rainfall Event at the Malomir Mine”… but seems a minor issue & plenty of positivity

2019 Half Year Trading Update” followed by Heavy Rainfall Event at the Malomir Mine” announcements from Petropavlovsk (POG)…

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Optibiotix new distribution deal fails to impress...BUT...

Optibiotix (OPTI) shares now trade at 72p to buy after the announcement of a new deal with a company called BioEnergiser Ltd for the online distribution of SlimBiome Medical in the UK. SlimBiome Medical is a CE-marked medical device which independent clinical studies show reduces hunger, cravings for sweet and savoury foods, and fat intake. Steve O’Hara tells me this is not because Optibiotix's own online sales are slowing. Far from it. But this is just another channel to market...

Subscribe to ShareProphets to access Premium Content
FOX
FOX

Fox Marble – acquisitions dispute escalates, Malesheva quarry operations suspended

Updating on Fox Marble (FOX) last month we noted enforceability of acquisition agreements challenged – though it believing the claims to be wholly unfounded. It now re-emphasises this “based on legal advice”, though “has suspended operations in its Malesheva quarry in Kosovo pending a resolution to the dispute”

PREMIUM CONTENT

OptiBiotix Health – positive scientific and commercial update

An update from OptiBiotix Health (OPTI); “Scientific and commercial update”...

Subscribe to ShareProphets to access Premium Content
Bear
PREMIUM CONTENT

Thoughts On Thomas Cook & Kier

I suggested selling Thomas Cook (TCG) back in May at 13p and at 5p today the company is still valued at £75 million. Given Friday’s announcement of the inevitable debt for equity swap, which “is not the outcome any of us wanted for our shareholders”, this is still far too high as will become apparent when the details are released...

Subscribe to ShareProphets to access Premium Content

OptiBiotix – deal momentum continues: now Japan

OptiBiotix (OPTI) has announced another license agreement to we loyal shareholders. This one is for the use of its ProBiotix’s LPLDL ingredient in cardiovascular food supplements in Japan and is set to mean a first LPLDL finished product placement on the Japanese market…

VRS
VRS
PREMIUM CONTENT

Lucian Miers' thoughts on Versarien: the only question is WHEN do the shares collapse?

I see that Versarien (VRS) has finally got rid of Patrick Abbott so that he can devote more time to defending the charges of securities fraud for which he has been indicted. I wrote back in March that his employment demonstrated a huge lack of judgement by CEO Neill Ricketts – as did the failure to disclose the matter at the time. That he should be fired so soon (eight days) after publicly standing by him a second time after further charges were revealed compounds the sense of management incompetence...

Subscribe to ShareProphets to access Premium Content
CRL
CRL
PREMIUM CONTENT

Creightons – we having said we expected the results to highlight the value…

Previously updating on cosmetics manufacturer and brand owner, Creightons (CRL) we stated, with the shares at 28.5p, we expect the results to highlight the value from such a valuation. The company has now announced results for its year ended 31st March 2019 and that it is “actively looking at opportunities to develop or invest in brands and businesses which will allow us to take the group forward and meet our medium term ambitions”

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Optibiotix new financial advisor/broker – no it's not placing ahoy

I have known that this move was in the offing for a couple of months. Quite simply the official broker to Optibiotix (OPTI), that is to say finnCap, is useless. But an AIM company needs a retained broker so it stays in place. However it is not publishing research nor is it putting forecasts into the market nor is it getting secondary buying of the stock by institutional investors. Finncap is FinnCrap...

Subscribe to ShareProphets to access Premium Content
BKY
BKY

Berkeley Energia – commences initial battery & EV metals drill programme

Berkeley Energia (BKY) “is pleased to announce the commencement of its initial (six hole) drill programme to test for critical battery and EV metals across its large licence holding in Western Spain”

PREMIUM CONTENT

A Welcome Slice Of Luck and Thoughts On Purplebricks

It is not easy being predominantly short in a market that is yet again flirting with all time highs and so a bit of luck is always welcome...

Subscribe to ShareProphets to access Premium Content
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|